Vyome Holdings (HIND) EBITDA Margin (2015 - 2026)
Vyome Holdings' EBITDA Margin came in at -3190.34% for Q2 2026, down 2547.31 percentage points from -643.03% a year earlier but up 378.19 percentage points from the prior quarter.
Powered by 
Analysis
Vyome Holdings (HIND) EBITDA Margin (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Vyome Holdings reported EBITDA Margin of -9181.94%, down 8916.94 percentage points year-over-year; for FY2025, it was -3265.60%, down 2920.78 percentage points from FY2024.
- EBITDA Margin carries a five-year change of -3173.41 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was -344.82% in FY2024 (-169.33 pp), -175.49% in FY2023 (+217.73 pp), -393.22% in FY2022 (+17.89 pp) and -411.11% in FY2021 (-318.92 pp).
- The five-year range for quarterly EBITDA Margin is -24753.82% (Q3 2025) to -95.26% (Q4 2023).
- Year-over-year, EBITDA Margin has declined for five consecutive quarters, with an average year-over-year change of -4340.26 percentage points over the last eight quarters.
- The fastest year-over-year change in EBITDA Margin over five years came in Q4 2022 (a gain of 655.61 percentage points), and the weakest in Q3 2025 (a drop of 24426.64 percentage points).
- Business Quant data shows HIND's EBITDA Margin at -3568.53% (Q1 2026), -3700.00% (Q4 2025) and -24753.82% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Vyome Holdings | 14.25 Mn | -11.86 Mn | 11,658.00 | -3,190.34% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,190.34% |
| Mar 31, 2026 | -3,568.53% |
| Dec 31, 2025 | -3,700.00% |
| Sep 30, 2025 | -24,753.82% |
| Jun 30, 2025 | -643.03% |
| Mar 31, 2025 | -98.44% |
| Dec 31, 2024 | -410.47% |
| Sep 30, 2024 | -327.18% |
| Jun 30, 2024 | -104.22% |
| Mar 31, 2024 | -113.37% |
| Dec 31, 2023 | -95.26% |
| Sep 30, 2023 | -177.73% |
| Jun 30, 2023 | -174.22% |
| Mar 31, 2023 | -244.12% |
| Dec 31, 2022 | -521.25% |
| Sep 30, 2022 | -418.66% |
| Jun 30, 2022 | -299.24% |
| Mar 31, 2022 | -308.16% |
| Dec 31, 2021 | -1,176.86% |
| Sep 30, 2021 | -372.90% |
API Access
Vyome Holdings EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=HIND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "HIND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=HIND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();